Latest Insights on FATE
The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]The Clash Over Interest Rates June 17, 2019 Great Stuff Jerome, you’ve got to let me know. Should I stay or should I go? The Federal Open Market Committee is meeting this week to decide the fate of U.S. monetary policy. In other words, the Fed is looking at interest rates. Federal Reserve Chairman Jerome Powell will hand down the central bank’s decision on Wednesday […]
Buy and Hold Stock Strategies Are Dead — but There’s Good News May 13, 2019 Stocks, Trading Strategies, Winning Investor Daily Investors have enjoyed a unique time in history. Now they need to adapt. And active strategies present the best opportunities.
1 Cannabis Trend to Watch in 2019 May 11, 2019 American Investor Today, Cannabis, Oil Charles Mizrahi and Anthony Planas share one innovative trend to fully usher pot into the mainstream. (3-minute read) 
Caution: Natural Resource Stocks Are Dropping — We Can Guide You February 15, 2019 American Investor Today The cyclicality of natural resources seems to attract dangerous manias. But we don’t follow the herd to the day’s hot bet. We help investors navigate the natural resource space.MEET OUR EXPERTS
Research Analyst
Editor of Alpha Investor
Director of VIP Services
Editor of Strategic Fortunes and three elite services
Chief Investment Strategist of Money & Markets
